PerkinElmer, Inc. Wins Merrill Upgrade

January 28, 2005 -- PerkinElmer Inc. reported yesterday that its fourth-quarter profit rose 36 percent on strong revenue in its health sciences business. Quarterly income grew to $38 million or 29 cents per share, up from $28 million or 22 cents per share a year ago. All Health Sciences activities account for about 75% of revenues. Revenue in that segment grew 8.5% for the year. The company said it intends to focus more on combining its genetic screening and drug discovery technologies, where it is a market leader. We think PerkinElmer is a good buy...